Insights of a Challenging Case: Lymphangioleiomyomatosis

Authors

  • Sana Siddiqui Dow University Of Health Sciences
  • Javeria Saif Dow International Medical College, Karachi - Pakistan
  • Miqlad Ilyas Dow International Medical College, Karachi - Pakistan
  • Mehwish Abbas Dow International Medical College, Karachi, Pakistan
  • Ansharah Khan Dow International Medical College, Karachi, Pakistan.
  • Saifullah Baig Ojha Institute of Chest Diseases (Dow University Of Health Science), Karachi - Pakistan

Abstract

Lymphangioleiomyomatosis (LAM) is progressive cystic lung disease that affects premenopausal women with the involvement of many organs of the body including the lungs. It commonly presents with dyspnea and cough, but its clinical course may be complicated by pleural effusions and recurrent pneumothorax. LAM is strongly associated with tuberous sclerosis complex (TSC) and may yield other clinically significant findings such as renal angiomyolipomas (AMLs) and lymphadenopathy. Investigations including radiological imaging, serum testing, and biopsies should be carefully considered when making a diagnosis as symptoms can be mistaken for other lung pathologies. The current mainstay of treatment is immunosuppressants and supportive therapy with bronchodilators and oxygen, while lung transplant is performed for end-stage disease. This case report details an unusual presentation of a 20-year-old female diagnosed with sporadic LAM following a previous pulmonary tuberculosis infection. She had a history of recurrent bilateral pneumothorax following initiation of antitubercular treatment (ATT). Diagnosis was made on the basis of clinical presentation and computed tomography (CT) scans; in addition, histopathological examination of the cervical lymph nodes revealed coexisting extrapulmonary tuberculosis. A brief literature review of the relevant topics is also discussed in this report.

Author Biographies

Javeria Saif, Dow International Medical College, Karachi - Pakistan

Dow International Medical College, Karachi - Pakistan

Miqlad Ilyas, Dow International Medical College, Karachi - Pakistan

Dow International Medical College, Karachi - Pakistan

Mehwish Abbas, Dow International Medical College, Karachi, Pakistan

Dow International Medical College, Karachi - Pakistan

Ansharah Khan, Dow International Medical College, Karachi, Pakistan.

Dow International Medical College, Karachi - Pakistan.

Saifullah Baig, Ojha Institute of Chest Diseases (Dow University Of Health Science), Karachi - Pakistan

Ojha Institute of Chest Diseases (Dow University Of Health Science), Karachi - Pakistan

References

Rhee JA, Adial A, Gumpeni R, Iftikhar A, Rhee JA. Lymphangioleiomyomatosis: a case report and review of literature. Cureus. 2019;11(1).

O'Mahony AM, Lynn E, Murphy DJ, Fabre A, McCarthy C. Lymphangioleiomyomatosis: a clinical review. Breathe (Sheff). 2020;16(2):200007.

Ryu JH, Moss J, Beck GJ, Lee JC, Brown KK, Chapman JT, Finlay GA, et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Res Crit Care Med.2006;173(1):105-11.

Johnson SR. Lymphangioleiomyomatosis. Eur Respir J 2006;27.

McCarthy C, Gupta N, Johnson SR, Yu JJ, McCormack FX.

Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management. Lancet Respir Med.2021.

Johnson SR. Lymphangioleiomyomatosis. Eur Respir J. 2006;27(5):1056-65.

Gupta N, Vassallo R, Wikenheiser-Brokamp KA, McCormack FX. Diffuse Cystic Lung Disease. Part I. Am J Respir Crit Care Med.2015;191(12):1354-66.

Taylor JR, Ryu J, Colby TV, Raffin TA: Lymphangioleiomyomatosis. N Engl J Med. 1990, 323:1254-60.

Harknett EC, Chang WY, Byrnes S, Johnson J, Lazor R, Cohen MM, et al. Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM: An Int J Med. 2011;104(11):971-9.

Sathirareuangchai S, Shimizu D, Vierkoetter KR. Pulmonary lymphangioleiomyomatosis: a case report and literature review. Hawaii J Health Soc Welf. 2020;79(7):224.

Lewandowska K, Oniszh K, Kopeć EA, Röhrenschef1 PR, Kuś J. Bacteriologically confirmed pulmonary tuberculosis in a patient with lymphangioleiomyomatosis accompanying tuberous sclerosis syndrome. Via Medica. 2011; 309-314.

Steagall WK, Pacheco-Rodriguez G, Darling TN, Torre O, Harari S, Moss J. The lymphangioleiomyomatosis lung cell and its human cell models. Am J Respir Cell Mol Biol.2018;58(6):678–83.

Cong CV, Anh TT, Ly TT, Duc NM. Pulmonary lymphangioleiomyomatosis (LAM): A literature overview and case report. Radiol Case Rep. 2022;17(5).

Henske EP, McCormack FX. Lymphangioleiomyomatosis – a wolf in sheep's clothing. J Clin Invest.2012; 122: 3807–3816.

Costello LC, Hartman TE, Ryu JH. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc. 2000;75((6)):591–594.

Franz DN, Brody A, Meyer C, Leonard J, Chuck G, Dabora S, et al. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med. 2001;164(4):661-8.

Cudzilo CJ, Szczesniak RD, Brody AS, Rattan MS, Krueger DA, Bissler JJ, et al.

Lymphangioleiomyomatosis screening in women with tuberous sclerosis. Chest. 2013;144:578–585.

Muzykewicz DA, Sharma A, Muse V, Numis AL, Rajagopal J, Thiele EA. TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex. J Med Genet. 2009;46((7):465–468.

Ryu JH, Sykes AM, Lee AS, Burger CD. Cystic lung disease is not uncommon in men with tuberous sclerosis complex. Respir Med. 2012;106(11):1586-90.

Urban T, Lazor R, Lacronique J, Murris M, Labrune S, Valeyre D, et al. Pulmonary lymphangioleiomyomatosis A study of 69 patients Groupe d'Etudes et de Recherche sur les Maladies “Orphelines†Pulmonaires (GERM“O“P) Medicine (Baltimore) 1999;78:321–37

Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J. 2010;35(1):14-26.

Bearz A, Rupolo M, Canzonieri V, Balestreri L, La Mura N, Berretta M, et al. Lymphangioleiomyomatosis: A case report and review of the literature. Tumori. 2004;90:528–531

Bonetti F, Chiodera PL, Pea M, Martignoni G, Bosi F, Zamboni G, et al.

Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis. Am J Surg Pathol. 1993;17(11):1092-102

McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Eng J Med. 2011;364(17):1595-606.

Pfizer’s RAPAMUNE® (sirolimus) Becomes First FDA-Approved Treatment for Lymphangioleiomyomatosis (LAM), A Rare Progressive Lung Disease. 2015. Pfizer. Available from URL:

https://www.pfizer.com/news/press-release/press-release-

detail/pfizer_s_rapamune_sirolimus_becomes_first_fda_approved_treatment_for_lym phangioleiomyomatosis_lam_a_rare_progressive_lung_disease

Kania BE, Jain S, West B, Courtney SW. Lymphangioleiomyomatosis: A Case Report and Review of Clinical Features and Management. Cureus. 2020;12(6):e8386.

Suárez I, Fünger SM, Kröger S, Rademacher J, Fätkenheuer G, Rybniker J. The Diagnosis and Treatment of Tuberculosis. Dtsch Arztebl Int. 2019;116(43):729-735.

World Health Organization. Global Tuberculosis Report. World Health Organization. 2022. Available from URL: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/globaltuberculosis-report-2022

Tahseen S, Khanzada FM, Baloch AQ, Abbas Q, Bhutto MM, Alizai AW, et al. (2020) Extrapulmonary tuberculosis in Pakistan- A nationwide multicenter retrospective study. PLoS ONE.15(4): e0232134.

Chai Q, Zhang Y and Liu CH. Mycobacterium tuberculosis: An Adaptable Pathogen Associated with Multiple Human Diseases. Front Cell Infect. Microbiol.2018;8:158.

Downloads

Published

2023-06-02

How to Cite

Siddiqui, S., Saif, J. ., Ilyas, M. ., Abbas, M. ., Khan, A. ., & Baig, S. . (2023). Insights of a Challenging Case: Lymphangioleiomyomatosis. Pakistan Journal of Chest Medicine, 29(2), 262–270. Retrieved from https://pjcm.net/index.php/pjcm/article/view/779

Issue

Section

Case Report